Enjin Co., Ltd. Logo

Enjin Co., Ltd.

PR firm for SMEs and medical institutions, offering consulting and a media matching platform.

7370 | T

Overview

Corporate Details

ISIN(s):
JP3168750002
LEI:
Country:
Japan
Address:
中央区銀座5−13−16
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Enjin Co., Ltd. is a public relations firm specializing in branding and strategic communications. The company provides comprehensive PR consulting services, including research, analysis, and long-term strategy development, primarily for small and medium-sized enterprises, corporations, and medical institutions. A key offering is "Medichoku," a proprietary media matching platform that connects clients directly with media outlets to secure exposure and enhance brand recognition. Additionally, Enjin operates a corporate venture capital arm to invest in and support startups, aiming to foster innovation and new market creation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-21 08:16
Registration Form
確認書
Japanese 8.7 KB
2025-08-21 08:15
Registration Form
有価証券報告書-第19期(2024/06/01-2025/05/31)
Japanese 1.0 MB
2025-06-17 07:27
Governance Information
訂正内部統制報告書-第16期(2021/06/01-2022/05/31)
Japanese 26.0 KB
2025-06-17 07:24
Governance Information
訂正内部統制報告書-第17期(2022/06/01-2023/05/31)
Japanese 26.6 KB
2025-06-17 07:19
Governance Information
訂正内部統制報告書-第18期(2023/06/01-2024/05/31)
Japanese 26.7 KB
2025-01-14 09:00
Report Publication Announcement
確認書
Japanese 8.8 KB
2025-01-14 08:54
Interim Report
半期報告書-第19期(2024/06/01-2025/05/31)
Japanese 219.6 KB
2024-08-26 08:02
Post-Annual General Meeting Information
臨時報告書
Japanese 28.9 KB
2024-08-26 07:51
Governance Information
内部統制報告書-第18期(2023/06/01-2024/05/31)
Japanese 23.3 KB
2024-08-26 07:44
Registration Form
確認書
Japanese 8.7 KB
2024-08-26 07:35
Registration Form
有価証券報告書-第18期(2023/06/01-2024/05/31)
Japanese 1008.8 KB
2024-04-12 08:17
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-04-12 08:13
Quarterly Report
四半期報告書-第18期第3四半期(2023/12/01-2024/02/29)
Japanese 167.8 KB
2024-01-12 07:42
Quarterly Report
確認書
Japanese 8.8 KB
2024-01-12 07:33
Quarterly Report
四半期報告書-第18期第2四半期(2023/09/01-2023/11/30)
Japanese 205.2 KB

Automate Your Workflow. Get a real-time feed of all Enjin Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enjin Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enjin Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.